MENU
UTMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

UTMD stock forecast, quote, news & analysis

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
UTMD
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for UTMD with price predictions
Oct 21, 2026

Momentum Indicator for UTMD turns positive, indicating new upward trend

UTMD saw its Momentum Indicator move above the 0 level on October 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 101 similar instances where the indicator turned positive. In 62 of the 101 cases, the stock moved higher in the following days. The odds of a move higher are at 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +0.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where UTMD advanced for three days, in 144 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

Bearish Trend Analysis

The 10-day RSI Indicator for UTMD moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In 12 of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for UTMD turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 29 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. UTMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.943) is normal, around the industry mean (4.952). P/E Ratio (22.780) is within average values for comparable stocks, (36.644). Projected Growth (PEG Ratio) (5.980) is also within normal values, averaging (4.143). Dividend Yield (0.017) settles around the average of (0.005) among similar stocks. P/S Ratio (6.549) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UTMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
published Dividends

UTMD paid dividends on October 05, 2026

Utah Medical Products UTMD Stock Dividends
А dividend of $0.31 per share was paid with a record date of October 05, 2026, and an ex-dividend date of September 17, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 9.3B. The market cap for tickers in the group ranges from 126 to 151.25B. ISRG holds the highest valuation in this group at 151.25B. The lowest valued company is HGYMF at 126.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 1%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 9%. PLSE experienced the highest price growth at 11%, while BNGO experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -33%. For the same stocks of the Industry, the average monthly volume growth was -8% and the average quarterly volume growth was 5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 53
Price Growth Rating: 52
SMR Rating: 81
Profit Risk Rating: 95
Seasonality Score: 16 (-100 ... +100)
View a ticker or compare two or three
UTMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of specialty medical devices for the healthcare industry

Industry PharmaceuticalsOther

Industry
Medical Specialties
Address
7043 South 300 West
Phone
+1 801 566-1200
Employees
152
Web
https://www.utahmed.com
Momentum Indicator for UTMD turns positive, indicating new upward trend